SEC Form 4 · accession 0001209191-17-066457
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven W Spector
Officer — EVP, General Counsel & Sec
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 15, 2017 | F | 234 | $30.23 | D | 12,640 | D | |
| Common StockF1,F2 | Dec 17, 2017 | F | 281 | $30.23 | D | 12,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The amount represents shares withheld for payment of tax liability relating to vesting of restricted stock units.
- F2The amount includes shares purchased under Arena's employee stock purchase plan prior to the reported transaction. The amount also gives effect to the one-for-ten reverse split of Arena's common stock effected June 16, 2017.